Back to search
FDAFDA · Food and drugs·Recall number D-1266-2015

Famotodine Tablets, USP, 20 mg Tablets, For Repacking Only, Packaged in 6500 Count Drums, Over the Counter. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. NDC: 64679-0374-09.

Published July 29, 2015 · Recall initiated: April 22, 2015

Summary

FDA records drug Class II recall D-1266-2015, published July 29, 2015 and initiated April 22, 2015. Recalling firm: Wockhardt Usa Inc.; Status: Terminated; Reported quantity: 539 Drums; Lot: Lot #: LN11320, Expiry: 7/31/2015; Lot #: LN11341, Expiry: 8/31/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Firm did not adequately investigate customer complaints.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Wockhardt Usa Inc.
Distributor
U.S. Nationwide including Puerto Rico.
Lot
Lot #: LN11320, Expiry: 7/31/2015; Lot #: LN11341, Expiry: 8/31/2015.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Famotodine Tablets, USP, 20 mg Tablets, For Repacking Only, Packaged in 6500 Count Drums, Over the Counter. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. NDC: 64679-0374-09. recalled?

Yes. FDA published recall D-1266-2015 on July 29, 2015. Reported hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.

What should I do if I have this product?

Voluntary: Firm initiated · Letter